AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26

Authors: Kuppen, PJK van der Eb, MM Jonges, LE Hagenaars, M Hokland, ME Nannmlark, U Goldfarb, RH Basse, PH Fleuren, GJ Hoeben, RC van de Velde, CJH
Citation: Pjk. Kuppen et al., Tumor structure and extracellular matrix as a possible barrier for therapeutic approaches using immune cells or adenoviruses in colorectal cancer, HISTOCHEM C, 115(1), 2001, pp. 67-72

Authors: Blom, WM de Bont, HJGM Meijerman, I Kuppen, PJK van der Meulen, H Mulder, GJ Nagelkerke, JF
Citation: Wm. Blom et al., Remodeling of the actin cytoskeleton of target hepatocytes and NK cells during induction of apoptosis, CELL MOTIL, 49(2), 2001, pp. 78-92

Authors: Koelemij, R Hagenaars, M Ensink, NG Eggermont, AMM Van De Velde, CJH Fleuren, GJ Kuppen, PJK
Citation: R. Koelemij et al., Administration of BiMAb-retargeted T cells in a rat hepatic metastases colon tumour model results in T-cell tumour infiltration independent of the route of administration, SC J IMMUN, 53(3), 2001, pp. 277-281

Authors: Jonges, LE Albertsson, P Van Vlierberghe, RLP Ensink, NG Johannson, BR Van de Velde, CJH Fleuren, GJ Nannmark, U Kuppen, PJK
Citation: Le. Jonges et al., The phenotypic heterogeneity of human natural killer cells: Presence of atleast 48 different subsets in the peripheral blood, SC J IMMUN, 53(2), 2001, pp. 103-110

Authors: Jonges, LE Nagelkerke, JF Ensink, NG van der Velde, EA Tollenaar, RAEM Fleuren, GJ van de Velde, CJH Morreau, H Kuppen, PJK
Citation: Le. Jonges et al., Caspase-3 activity as a prognostic factor in colorectal carcinoma, LAB INV, 81(5), 2001, pp. 681-688

Authors: van der Burg, SH de Cock, K Menon, AG Franken, KLMC Palmen, M Redeker, A Drijfhout, JW Kuppen, PJK van de Velde, CJH Erdile, L Tollenaar, RAEM Melief, CJM Offringa, R
Citation: Sh. Van Der Burg et al., Long lasting p53-specific T cell memory responses in the absence of anti-p53 antibodies in patients with resected primary colorectal cancer, EUR J IMMUN, 31(1), 2001, pp. 146-155

Authors: Luo, DZ Vanderkerken, K Chen, MC Vermijlen, D Asosingh, K Willems, E Triantis, V Eizirik, DL Kuppen, PJK Wisse, E
Citation: Dz. Luo et al., Rat hepatic natural killer cells (Pit cells) express mRNA and protein similar to in vitro interleukin-2 activated spleen natural killer cells, CELL IMMUN, 210(1), 2001, pp. 41-48

Authors: Geutskens, SB van der Eb, MM Plomp, AC Jonges, LE Cramer, SJ Ensink, NG Kuppen, PJK Hoeben, RC
Citation: Sb. Geutskens et al., Recombinant adenoviral vectors have adjuvant activity and stimulate T cellresponses against tumor cells, GENE THER, 7(16), 2000, pp. 1410-1416

Authors: Bremers, AJA Kuppen, PJK Parmiani, G
Citation: Aja. Bremers et al., Tumour immunotherapy: the adjuvant treatment of the 21st century?, EUR J SUR O, 26(4), 2000, pp. 418-424

Authors: Hagenaars, M Ensink, NG Eggermont, AMM van der Velde, EA van de Velde, CJH Fleuren, GJ Kuppen, PJK
Citation: M. Hagenaars et al., Endogenous natural killer cells do not play a role in antitumor effects induced by interleukin-2 in a syngeneic rat colon tumor model, CANCER IMMU, 48(10), 2000, pp. 561-568

Authors: Hagenaars, M Koelemij, R Ensink, NG van Eendenburg, JDH van Vlierberghe, RLP Eggermont, AMM van de Velde, CJH Fleuren, GJ Kuppen, PJK
Citation: M. Hagenaars et al., The development of novel mouse monoclonal antibodies against the CC531 ratcolon adenocarcinoma, CLIN EXP M, 18(4), 2000, pp. 281-289

Authors: Hagenaars, M Ensink, NG Basse, PH Hokland, M Nannmark, U Eggermont, AMM van de Velde, CJH Fleuren, GJ Kuppen, PJK
Citation: M. Hagenaars et al., The microscopic anatomy of experimental rat CC531 colon tumour metastases:Consequences for immunotherapy?, CLIN EXP M, 18(2), 2000, pp. 189-196

Authors: Jonges, LE Giezeman-Smits, KM van Vlierberghe, RLP Ensink, NG Hagenaars, M Joly, E Eggermont, AMM van de Velde, CJH Fleuren, GJ Kuppen, PJK
Citation: Le. Jonges et al., NK cells modulate MHC class I expression on tumor cells and their susceptibility to lysis, IMMUNOBIOL, 202(4), 2000, pp. 326-338

Authors: Kim, MH Kitson, RP Albertsson, P Nannmark, U Basse, PH Kuppen, PJK Hokland, ME Goldfarb, RH
Citation: Mh. Kim et al., Secreted and membrane-associated matrix metalloproteinases of IL-2-activated NK cells and their inhibitors, J IMMUNOL, 164(11), 2000, pp. 5883-5889

Authors: Bremers, AJA Andreola, S Leo, E Gallino, F Rini, F Lombardo, C Belli, F Kuppen, PJK Parmiani, G Castelli, C
Citation: Aja. Bremers et al., T cell responses in colorectal cancer patients: Evidence for class IIHLA-restricted recognition of shared tumor-associated antigens, INT J CANC, 88(6), 2000, pp. 956-961

Authors: Vahrmeijer, AL van Dierendonck, JH Keizer, HJ Beijnen, JH Tollenaar, RAEM Pijl, MEJ Marinelli, A Kuppen, PJK van Bockel, JH Mulder, GJ van de Velde, CJH
Citation: Al. Vahrmeijer et al., Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer confined to the liver, BR J CANC, 82(9), 2000, pp. 1539-1546

Authors: Koelemij, R Kuppen, PJK van de Velde, CJH Fleuren, GJ Hagenaars, M Eggermont, AMM
Citation: R. Koelemij et al., Bispecific antibodies in cancer therapy, from the laboratory to the clinic, J IMMUNOTH, 22(6), 1999, pp. 514-524

Authors: Pietersen, AM van der Eb, MM Rademaker, HJ van den Wollenberg, DJM Rabelink, MJWE Kuppen, PJK van Dierendonck, JH van Ormondt, H Masman, D van de Velde, CJH van der Eb, AJ Hoeben, RC Noteborn, MHM
Citation: Am. Pietersen et al., Specific tumor-cell killing with adenovirus vectors containing the apoptingene, GENE THER, 6(5), 1999, pp. 882-892

Authors: Blom, WM De Bont, HJGM Meijerman, I Kuppen, PJK Mulder, GJ Nagelkerke, JF
Citation: Wm. Blom et al., Interleukin-2-activated natural killer cells can induce both apoptosis andnecrosis in rat hepatocytes, HEPATOLOGY, 29(3), 1999, pp. 785-792

Authors: Hagenaars, M Ensink, NG Jonges, LE Chambers, WH Eggermont, AMM van de Velde, CJH Fleuren, GJ Kuppen, PJK
Citation: M. Hagenaars et al., The development of a bi-specific anti-CD 161AxAnti-tumor antibody for rat NK cell targeting, IMMUNOBIOL, 200(1), 1999, pp. 31-48

Authors: Luo, DZ Vermijlen, D Vanderkerken, K Kuppen, PJK Seynaeve, C Eddouks, M Baekeland, M Wisse, E
Citation: Dz. Luo et al., Involvement of LFA-1 in hepatic NK cell (pit cell)-mediated cytolysis and apoptosis of colon carcinoma cells, J HEPATOL, 31(1), 1999, pp. 110-116

Authors: Giezeman-Smits, KM Gorter, A van Vlierberghe, RLP Von Eendenburg, JDH Eggermont, AMM Fleuren, GJ Kuppen, PJK
Citation: Km. Giezeman-smits et al., The regulatory role of CD45 on rat NK cells in target cell lysis, J IMMUNOL, 163(1), 1999, pp. 71-76

Authors: Adobati, E Zacchetti, A Perico, ME Cremonesi, F Rasi, G Vallebona, PS Hagenaars, M Kuppen, PJK Pastan, I Panza, L Russo, G Colnaghi, MI Canevari, S
Citation: E. Adobati et al., Expression profile of saccharide epitope CaMBr1 in normal and neoplastic tissue from dogs, cats, and rats: Implication for the development of human-derived cancer vaccines, HISTOCHEM J, 31(11), 1999, pp. 729-737

Authors: Hendriks, JMH Van Schil, PEY Van Oosterom, AAT Kuppen, PJK Van Marck, E Eyskens, E
Citation: Jmh. Hendriks et al., Isolated lung perfusion with melphalan prolongs survival in a rat model ofmetastatic pulmonary adenocarcinoma, EUR SURG RE, 31(3), 1999, pp. 267-271

Authors: De Vries, MR Rinkes, IHMB Swaak, AJG Hack, CE Van de Velde, CJH Wiggers, T Tollenaar, RAEM Kuppen, PJK Eggermont, AMM
Citation: Mr. De Vries et al., Acute-phase response patterns in isolated hepatic perfusion with tumour necrosis factor alpha (TNF-alpha) and melphalan in patients with colorectal liver metastases, EUR J CL IN, 29(6), 1999, pp. 553-560
Risultati: 1-25 | 26-26